title: Author reply: Biologics or biosimilars: What is the difference?
authors.affiliation: Department of Dermatology and Venereology, All India Institute of Medical Sciences, New Delhi, India.
authors.forename: Vinod Kumar
authors.initials: VK
authors.lastname: Sharma
authors.affiliation: Department of Dermatology and Venereology, All India Institute of Medical Sciences, New Delhi, India.
authors.forename: Neetu
authors.initials: N
authors.lastname: Bhari
authors.affiliation: Department of Dermatology and Venereology, All India Institute of Medical Sciences, New Delhi, India.
authors.forename: Somesh
authors.initials: S
authors.lastname: Gupta
authors.affiliation: Department of Dermatology and Venereology, All India Institute of Medical Sciences, New Delhi, India.
authors.forename: Kanika
authors.initials: K
authors.lastname: Sahni
authors.affiliation: Department of Dermatology and Venereology, All India Institute of Medical Sciences, New Delhi, India.
authors.forename: Neena
authors.initials: N
authors.lastname: Khanna
authors.affiliation: Department of Dermatology and Venereology, All India Institute of Medical Sciences, New Delhi, India.
authors.forename: M
authors.initials: M
authors.lastname: Ramam
authors.affiliation: Department of Dermatology and Venereology, All India Institute of Medical Sciences, New Delhi, India.
authors.forename: G
authors.initials: G
authors.lastname: Sethuraman
mesh_terms: D001685:Biological Factors / Q000627:therapeutic use*; D059451:Biosimilar Pharmaceuticals / Q000627:therapeutic use*; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D010392:Pemphigus / Q000175:diagnosis / Q000188:drug therapy; D000069283:Rituximab / Q000627:therapeutic use
chemical_list: D001685:Biological Factors; D059451:Biosimilar Pharmaceuticals; D007155:Immunologic Factors; D000069283:Rituximab